Many patients benefit from combining metformin with SGLT2 inhibitors or GLP1 receptor agonists for added cardiovascular and renal protection
These mucosal regenerative effects have been consistently demonstrated in experimental animal models of IBD (87), complementing their currently approved use of GLP-2 analogs in short bowel syndrome (88, 89)
Its designed for GLP-1 users but beneficial for anyone needing clean, plant-based protein and digestive support
In a clinical trial in 42 individuals with type 2 diabetes, 300 mg of a chlorogenic acid-containing plant extract daily for four weeks significantly reduced fasting plasma glucose, C-reactive protein (CRP), and liver enzymes compared with placebo (Abidov 2006)
This is about education and the effects GLP-1 use is having on your brand
The LifeRx.md community reports decreased enjoyment, tolerance, frequency, and volume of alcohol consumption